Pitt Street Research is run by Stuart Roberts (one of the authors of this report) who is a well-known two-decade veteran of the Australian biotech industry. He previously worked as a biotech analyst at a couple of leading broking firms.
You pay for coverage by Pitt Street Research. It fills the void in coverage of smaller biotechs by the well-known sell-side analysts.
A then-unloved Neuren commissioned coverage by Pitt Street Research back in late 2018 for this very reason.
https://lifesciencessummit.co.nz/speaker/stuart-roberts/
Daily happenings?., page-274
-
- There are more pages in this discussion • 245 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 35499 | 1 |
View Market Depth
| Last trade - 07.00am 02/07/2024 (20 minute delay) ? |
| PTX (ASX) Chart |
Day chart unavailable